Antigen News and Research

RSS

Innovative device shows promise in capturing and releasing circulating tumor cells

For years, bioengineer Yaling Liu has been in pursuit of the deadly tumor cell. Liu has been perfecting a microfluidic device the size of two quarters that has the ability to catch and release circulating tumor cells (CTCs)--cancer cells that circulate in a cancer patient's blood.

19 Apr 2018

Environmental pollutants found to worsen rheumatoid arthritis

Scientists have uncovered a link between the risk of developing rheumatoid arthritis and environmental pollutants, such as cigarette smoke.

19 Apr 2018

New microscopy techniques allow quasi-biochemical studies on living T cells

A joint study by the TU Wien and the Vienna School of Medicine has now led to a surprising result. While most opinion leaders in the field reasoned that T cell receptors must interact with one another for effective immune-signaling, the Viennese study shows: T cell receptors act alone. The study has now been published in the journal Nature Immunology.

19 Apr 2018

Engineered immune cells clear deadly pediatric brain tumor in mice

Engineered human immune cells can vanquish a deadly pediatric brain tumor in a mouse model, a study from the Stanford University School of Medicine has demonstrated.

16 Apr 2018

Research reveals immune suppressive role of soluble antibodies in tumor progression

Wistar researchers have found that soluble antibodies promote tumor progression by inducing accumulation of myeloid-derived suppressor cells (MDSCs) in pre-clinical cancer models. Results were published online in Cancer Immunology Research.

13 Apr 2018

Nanotechnology-based treatment approach shown to be effective in mouse models of lung cancer

The most common type of lung cancer, non-small cell lung cancer (NSCLC), continues to be difficult to treat, with five year survival rates of about 36 percent for stage 3A tumors.

11 Apr 2018

Research identifies link between rare gene variants and survival after blood and marrow transplant

Blood and marrow transplant, or BMT, is a lifesaving and effective treatment for many patients, but the procedure can cause serious and life-threatening complications.

10 Apr 2018

Theresa May to launch £75m drive against prostate cancer

British Prime Minister Theresa May has declared war against prostate cancer. Yearly, 47,000 men are UK are diagnosed with this cancer and 11,000 succumb to it, according to reports. Recent reports show that prostate cancer in men kills more than breast cancer does in women.

10 Apr 2018

Prostate cancer on the rise and detected late in the UK finds report

As many as 37 percent of all prostate cancers are detected late or in advanced stages in the UK, finds a new report from the charity Orchid. The report suggests that most of these cancers are detected at stages 3 and 4. Statistics show that nearly 47,000 men are diagnosed with prostate cancer annually and 11,000 succumb to the disease each year.

9 Apr 2018

Researchers develop improved method for calculating type 1 diabetes risk

An international research group headed by scientists from Helmholtz Zentrum München has developed a method for calculating the risk for developing type 1 diabetes that is significantly superior to earlier methods.

4 Apr 2018

Researchers working to develop new system for early prostate cancer diagnosis

Researchers of the Universitat Politècnica de València and the Universidad de Granada, together with doctors from the Hospital Clínic Universitari de València are working on the development of a new system to help diagnose prostate cancer. The work being developed is part of the SICAP project.

3 Apr 2018

Scientists develop futuristic gene therapy for liver cancer

Genetically engineered human T cells that are effective at fighting liver cancer in mice may one day help patients fight liver cancer, say researchers.

3 Apr 2018

Researchers create new compound that appears to activate cancer-fighting T cells

Invariant natural killer T (iNKT) cells are powerful weapons our body's immune systems count on to fight infection and combat diseases like cancer, multiple sclerosis, and lupus. Finding ways to spark these potent cells into action could lead to more effective cancer treatments and vaccines.

2 Apr 2018

New $3.2 million grant funds research to advance promising malaria vaccine

The Global Health Innovative Technology Fund has awarded the University of Florida and partners in the United States and Japan $3.2 million to advance a promising vaccine to prevent transmission of malaria.

29 Mar 2018

Measurement of tumor's metabolic activity could help determine prostate cancer prognosis

A new approach to analyzing prostate gland tissue may help address a major challenge in treating prostate cancer - determining which tumors are unlikely to progress and which could be life threatening and require treatment.

27 Mar 2018

American Gene Technologies receives second immuno-oncology patent

American Gene Technologies International Inc., a leading gene and cell therapy company, today announced receipt of a second immuno-oncology patent on the stimulation of gamma delta T cells for treating solid tumors in epithelial cancers.

20 Mar 2018

Artificial sweetener sucralose worsens gut inflammation in mice with Crohn's disease

In a study that has implications for humans with inflammatory diseases, researchers from Case Western Reserve University School of Medicine and colleagues have found that, given over a six-week period, the artificial sweetener sucralose, known by the brand name Splenda, worsens gut inflammation in mice with Crohn's-like disease, but had no substantive effect on those without the condition.

15 Mar 2018

Higher doses of radiation do not translate into longer survival for prostate cancer patients

A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment.

15 Mar 2018

Scientists link protein to seizure suppression

According to a new study, seizures can be suppressed in the brain by a protein called T-cell intracellular antigen-1 (TIA-1).

8 Mar 2018

New PET imaging agent allows early detection of prostate cancer relapse

An Italian study featured in the March issue of The Journal of Nuclear Medicine demonstrates that a novel nuclear medicine imaging agent targeting copper accumulation in tumors can detect prostate cancer recurrence early in patients with biochemical relapse (rising prostate-specific antigen [PSA] level).

5 Mar 2018

Antigen News and Research

Innovative device shows promise in capturing and releasing circulating tumor cells

Environmental pollutants found to worsen rheumatoid arthritis

New microscopy techniques allow quasi-biochemical studies on living T cells

Engineered immune cells clear deadly pediatric brain tumor in mice

Research reveals immune suppressive role of soluble antibodies in tumor progression

Nanotechnology-based treatment approach shown to be effective in mouse models of lung cancer

Research identifies link between rare gene variants and survival after blood and marrow transplant

Theresa May to launch £75m drive against prostate cancer

Prostate cancer on the rise and detected late in the UK finds report

Researchers develop improved method for calculating type 1 diabetes risk

Researchers working to develop new system for early prostate cancer diagnosis

Scientists develop futuristic gene therapy for liver cancer

Researchers create new compound that appears to activate cancer-fighting T cells

New $3.2 million grant funds research to advance promising malaria vaccine

Measurement of tumor's metabolic activity could help determine prostate cancer prognosis

American Gene Technologies receives second immuno-oncology patent

Artificial sweetener sucralose worsens gut inflammation in mice with Crohn's disease

Higher doses of radiation do not translate into longer survival for prostate cancer patients

Scientists link protein to seizure suppression

New PET imaging agent allows early detection of prostate cancer relapse

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News